Skip to content
Politically.com Search all
Menu

2026 · 3rd Quarter (July 1 - Sep 30)

RECCE PHARMACEUTICALS LTD

Filed by RK STRATEGIES, INC..

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-11-04 06:26:19 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 20, 2026
Income
$20,000.00
Expenses
Not reported
Filing UUID
6acc4c92-f126-4c44-a751-814aa6dd49e3
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

VET · Veterans

General wound care issues

HCR · Health Issues

General healthcare/wound care issues Pandemic and All Hazards Preparedness Act Reauthorization Appropriations Issues

DEF · Defense

General biodefense/wound care issues Pandemic and All Hazards Preparedness Act Reauthorization Other Appropriations Issues Related to Wound Care/Biodefense

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.